| Kristi Gregory, MS OTRL CHT | |
|
1115 Boulders Pkwy Ste 100a, North Chesterfield, VA 23225-4067 | |
| (804) 330-8165 | |
| (804) 287-2786 |
| Full Name | Kristi Gregory |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 24 Years |
| Location | 1115 Boulders Pkwy Ste 100a, North Chesterfield, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124084264 | NPI | - | NPPES |
| 1124084264 | Medicaid | VA | |
| 192945 | Other | VA | BCBS OCCUPATIONAL THERAPY |
| 7261398 | Other | VA | AETNA |
| P00425882 | Other | VA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 0119003030 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthovirginia Inc | 0547157224 | 492 |
News Archive
A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer's disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy.
A hospital in Switzerland has announced it will allow assisted suicide on its premises for terminally ill patients.
Phosphagenics Limited today announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.
Scientists have just discovered that a small region of a cellular protein that helps long-term memories form also drives the neurodegeneration seen in Amyotrophic Lateral Sclerosis (ALS). This small part of the Ataxin-2 protein thus works for good and for bad.
Priming, an unconscious phenomenon that causes the context of information to change the way we think or behave, has frustrated scientists as they have unsuccessfully attempted to understand how it works.
› Verified 4 days ago
| Provider Name | Orthovirginia Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1487671822 PECOS PAC ID: 0547157224 Enrollment ID: O20040228000320 |
News Archive
A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer's disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy.
A hospital in Switzerland has announced it will allow assisted suicide on its premises for terminally ill patients.
Phosphagenics Limited today announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.
Scientists have just discovered that a small region of a cellular protein that helps long-term memories form also drives the neurodegeneration seen in Amyotrophic Lateral Sclerosis (ALS). This small part of the Ataxin-2 protein thus works for good and for bad.
Priming, an unconscious phenomenon that causes the context of information to change the way we think or behave, has frustrated scientists as they have unsuccessfully attempted to understand how it works.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristi Gregory, MS OTRL CHT 1115 Boulders Pkwy Ste 200, North Chesterfield, VA 23225-4067 Ph: (804) 915-4607 | Kristi Gregory, MS OTRL CHT 1115 Boulders Pkwy Ste 100a, North Chesterfield, VA 23225-4067 Ph: (804) 330-8165 |
News Archive
A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer's disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy.
A hospital in Switzerland has announced it will allow assisted suicide on its premises for terminally ill patients.
Phosphagenics Limited today announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.
Scientists have just discovered that a small region of a cellular protein that helps long-term memories form also drives the neurodegeneration seen in Amyotrophic Lateral Sclerosis (ALS). This small part of the Ataxin-2 protein thus works for good and for bad.
Priming, an unconscious phenomenon that causes the context of information to change the way we think or behave, has frustrated scientists as they have unsuccessfully attempted to understand how it works.
› Verified 4 days ago
Stella Matthews, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 8005 W Mount Bella Rd, North Chesterfield, VA 23235 Phone: 866-370-8206 | |
Meghan O Reynolds, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9325 Midlothian Tpke Ste A, North Chesterfield, VA 23235 Phone: 757-490-3223 Fax: 757-490-2936 | |
Tatiana Schrader, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9325 Midlothian Tpke Ste A, North Chesterfield, VA 23235 Phone: 757-490-3223 | |
Miss Blair Jones, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9325 Midlothian Tpke Ste A, North Chesterfield, VA 23235 Phone: 757-490-3223 Fax: 757-490-3223 | |
Ms. Sarah Emily Hopkins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9919 Castle Glen Ter, North Chesterfield, VA 23236 Phone: 804-647-3613 | |
Danielle Moll, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9325 Midlothian Tpke Ste A, North Chesterfield, VA 23235 Phone: 757-490-3223 |